The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients.
暂无分享,去创建一个
G. Saposnik | B. Yoon | J. S. Lee | Juneyoung Lee | J. Cha | Byung‐Chul Lee | H. Bae | K. Kang | K. Yu | Jong-Moo Park | Yong‐Jin Cho | K. Hong | J. Lee | J. Kim | J. Choi | Moon‐Ku Han | Ji Sung Lee | Dong-Eog Kim | Dae-Hyun Kim | S. Lee | Y. Ko | K. Lee | T. Park | Sang-soon Park | J. S. Lee | Jun Lee | Sang-Soon Park
[1] A. Demchuk,et al. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[2] Peter Sandercock,et al. Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-Analysis of 55 Studies , 2012, Stroke.
[3] Ning Zhang,et al. A Risk Score Based on Get With the Guidelines–Stroke Program Data Works in Patients With Acute Ischemic Stroke in China , 2012, Stroke.
[4] Eric E. Smith,et al. Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator , 2012, Stroke.
[5] Geoff Cohen,et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis , 2012, The Lancet.
[6] Geoff Cohen,et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial , 2012, The Lancet.
[7] Gary A. Ford,et al. Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase: Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score , 2012, Stroke.
[8] P. Austin,et al. The iScore Predicts Effectiveness of Thrombolytic Therapy for Acute Ischemic Stroke , 2012, Stroke.
[9] M. Kaste,et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN Score , 2012, Annals of neurology.
[10] M. Kaste,et al. Predicting outcome of IV thrombolysis–treated ischemic stroke patients , 2012, Neurology.
[11] P. Austin,et al. The iScore Predicts Poor Functional Outcomes Early After Hospitalization for an Acute Ischemic Stroke , 2011, Stroke.
[12] C. Gerloff,et al. Pretreatment Diffusion-Weighted Imaging Lesion Volume Predicts Favorable Outcome After Intravenous Thrombolysis With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke , 2011, Stroke.
[13] Gustavo Saposnik,et al. IScore: A Risk Score to Predict Death Early After Hospitalization for an Acute Ischemic Stroke , 2011, Circulation.
[14] J. Jeng,et al. Get With The Guidelines-Stroke Performance Indicators: Surveillance of Stroke Care in the Taiwan Stroke Registry: Get With The Guidelines-Stroke in Taiwan , 2010, Circulation.
[15] V. Hachinski,et al. The Canadian Neurological Scale and the NIHSS: Development and Validation of a Simple Conversion Model , 2010, Cerebrovascular Diseases.
[16] D. Tanné,et al. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[17] G Schlaug,et al. The HAT Score , 2008, Neurology.
[18] Zsolt Garami,et al. Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke , 2007, Stroke.
[19] Werner Hacke,et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.
[20] David M. Kent,et al. The Stroke–Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke , 2006, Stroke.
[21] Scott Hamilton,et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.
[22] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .